A primary biliary cholangitis (PBC) diagnosis can be life-changing. For many, it’s an emotional journey filled with questions ...

Discussions surrounding gluten have taken the centre-stage since quite some time now Several individuals are not tolerant of ...

Primary biliary cholangitis (PBC) can deliver a significant blow to patients' quality of life, especially if they are not ...

The wrong diet and lifestyle are bigger triggers for fatty liver than alcohol. Have a low calorie diet between 1,200 to 1,400 ...

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease.

reassuringly narrated stories that present all that’s known about the liver, diseases related to it, transplant surgery, and ...

引言胆道癌（BTC）起病隐匿，患者诊断时常处于晚期，以系统治疗为主，预后较差。自 2010 年吉西他滨联合顺铂（GC）确立为晚期 BTC ...

Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the drug. Tasfygo (tasurgratinib succinate; formerly E7090), a small-molecule ...

Primary biliary cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, resulting in chronic cholestasis, portal inflammation ...

Dichloromethane, a volatile solvent commonly used in industrial applications, has been banned in products in many areas, ...

Cite this: The Intestinal Absorption of Biliary and Dietary Cholesterol as a Drug Target for Lowering the Plasma Cholesterol Level - Medscape - Jan 01, 2003.

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).